Recent Finacing
Recent Raise
Pinpoint Therapeutics develops PPT1-targeting autophagy inhibitors for treatment-refractory cancers, intended as single-agent or combination therapies and advanced into clinical testing.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Pinpoint Therapeutics.
